Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 févr. 2026 08h00 HE | Source: SNS Insider pvt ltd

Spectrometry Market Size to Hit USD 36.85 Billion by 2033, Driven by Rising Demand for Rapid and Accurate Analytical Testing – SNS Insider

Austin, United States, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Spectrometry Market Size & Growth Analysis: "According to SNS Insider, The Spectrometry Market was valued at USD 20.04 Billion in 2025...
17 févr. 2026 11h32 HE | Source: Research and Markets

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031" drug pipelines has been added to ResearchAndMarkets.com's...
17 févr. 2026 05h30 HE | Source: Salipro Biotech AB

Salipro Biotech Expands Global Intellectual Property Estate with Key U.S. Patent Grant

New U.S. patent secures long term protection for the Salipro® platform technologies, extending exclusivity until 2042.
16 févr. 2026 07h00 HE | Source: Juvenescence

Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City

Jennings-Brown will drive AI and technology strategy and lead the development of capabilities enabling discovery of therapeutics targeting fundamental aging mechanisms Offices in Abu Dhabi's premier...
13 févr. 2026 08h00 HE | Source: Advanced Biomed Inc.

Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery

Tainan, Taiwan, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative...
12 févr. 2026 11h21 HE | Source: Research and Markets

Writing Clinical Research with Integrity Training Course: Focus on Ethical Standards, Data Integrity, and Plagiarism Prevention (ONLINE EVENT: Apr 20, 2026)

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course...
12 févr. 2026 11h07 HE | Source: Research and Markets

Global Pharmaceutical R&D Directory 2026: Licensing Trends, Biotechnology Advancements, Preclinical and Clinical Development, Avenues for Growth and Innovation

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "The Global Pharmaceutical R&D Directory" directory has been added to ResearchAndMarkets.com's offering. The Global Pharmaceutical R&D...
11 févr. 2026 14h45 HE | Source: Deep Origin

Deep Origin Congratulates Isomorphic Labs on Catching Up

Deep Origin presented results for DODock last year that outperformed AlphaFold 3 and other leading methods; congratulates Isomorphic Labs on catching up
09 févr. 2026 11h00 HE | Source: Carterra

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

Carterra launches Vega™, the industry’s first 48-channel HT-SPR platform, enabling high-resolution, label-free primary screening for modern drug discovery.
29 janv. 2026 04h10 HE | Source: Research and Markets

EU and FDA GCP (Good Clinical Practice) and Clinical Research Training Course: ICH GCP R3Hot Inspection Topics Updates (Online Event: May 19, 2026)

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "GCP (Good Clinical Practice) and Clinical Research Update - Hot Inspection Topics Training Course (May 19, 2026)" training has been added to ...

Page suivante